Una presa male: un quotidiano manca l'obiettivo sui test prenatali
Il 1° gennaio 2022, il New York Times ha pubblicato un articolo, "When They Warn of Rare Disorders, These Prenatal Tests are Usually Wrong", sostenendo che i risultati positivi dei test degli screening genetici prenatali sono errati l'85% delle volte. L'articolo discute i cinque test di microdelezione più comuni e condivide storie personali di donne che hanno sperimentato paura e ansia, dopo aver ricevuto falsi positivi.
The article presents a skewed view of both screening and rare diseases, which has caused a storm on social media in the rare community. Genetic counselor Elizabeth Kearney joins the conversation, expertly addressing the article’s inaccuracies and assumptions.
Passate all'azione!
Send a letter to the NY Times: https://www.nytimes.com/2022/01/08/opinion/letters/prenatal-genetic-tests.html
Ultime notizie da Know Rare
Elizabeth Kearney
Elizabeth Kearney, MS, CGC, MBA is a licensed genetic counselor and founder of Mainstream Genomics, LLC, which aims to help people who are pregnant or planning for pregnancy find the right genetic services for them. She is a past President of the National Society of Genetic Counselors and speakers nationally and regionally as a thought leader in genetic service delivery. Liz has a Master’s in Human Genetics From the University of Michigan and an MBA from Kellogg School of Management at Northwestern University. She can be reached via her website or email.